News

Prompt Vertebroplasty Eased Acute Fracture Pain


 

From The Lancet

By using conservative pain management as a comparator, Dr. Klazen and her colleagues noted, vertebroplasty was tested against “the reference treatment and thus provides the clinician with directly applicable information about how to best treat the patient.”

Dr. Klazen and her colleagues noted that ZonMw and Cook Medical, the sponsors of the study “had no role in study design, data collection, data analysis, data interpretation, writing of the report, or the decision to submit for publication.”

Pages

Recommended Reading

FDA Stands Pat on Long-Term Bisphosphonates
MDedge Endocrinology
Age May Alter Bisphosphonate Effect on Stenosis
MDedge Endocrinology
Bone Loss in Adolescents on DMPA Tied to Vitamin D
MDedge Endocrinology
PPIs Raise Risk of Some Fractures, but Not Hip
MDedge Endocrinology
Therapeutic Retinoids Do Not Raise Risk of Fracture
MDedge Endocrinology
Bone Mineral Density Loss Reversible Post DMPA
MDedge Endocrinology
Annual High-Dose Vit. D Raises Fall, Break Risks
MDedge Endocrinology
Agency Cautions on PPI-Related Vulnerabilities
MDedge Endocrinology
Fracture Risk Spikes With Thiazolidinediones
MDedge Endocrinology
Lupus Patients Need 2,000 IU Daily Vitamin D
MDedge Endocrinology